Makoto Nishio

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

January, 2025

Makoto Nishio

Jan 31, 2025, 12:46 | Insight

5 papers about lung cancer by Stephen Liu

Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers…

Oct 20, 2024, 17:47 | Drugs

Stephen V Liu: Long-term survival with nivolumab and ipilimumab in advanced NSCLC

Stephen V Liu shared on X: "Long-term survival (median f/u 73.7m) with nivolumab and ipilimumab…

Apr 19, 2024, 15:52 | Drugs

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial

FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…

All: 3 Posts: 1 - 100

'

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment

'

Oncologist Near Me - Hagop Kantarjian: A Legend in Leukemia Research and Treatment

'

New Paper Alert: Botensilimab and Balstilimab in Relapsed/Refractory Metastatic Sarcomas

'

Best of ASCOGI25

'

Egypt Cancer Society (ECS) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023